28413643|t|Cytotoxic and antimigratory effects of Cratoxy formosum extract against HepG2 liver cancer cells
28413643|a|The aim of the present study was to investigate the molecular mechanisms underlying Cratoxylum formosum (CF) Dyer-induced cancer cell death and antimigratory effects in HepG2 liver cancer cells. The cytotoxic, antiproliferative and antimigratory effects of CF leaf extract on human liver cancer HepG2 cell lines were evaluated using sulforhodamine B, colony formation, and wound healing assays. In addition, apoptosis induction mechanisms were investigated via reactive oxygen species (ROS) formation, caspase 3 activities, and mitochondrial membrane potential (ΔΨm) disruption. Gene expression and apoptosis -associated protein levels were measured by reverse transcription-quantitative polymerase chain reaction and western blotting. CF induced HepG2 cell death in a time- and dose-dependent manner with half maximal inhibitory concentration values of 219.03±9.96 and 124.90±6.86 µg/ml at 24 and 48 h, respectively. Treatment with CF caused a significant and dose-dependent decrease in colony forming ability and cell migration. Furthermore, the present study demonstrated that CF induced ROS formation, increased caspase 3 activities, decreased the ΔΨm, and caused HepG2 apoptosis. CF marginally decreased the expression level of the cell cycle regulatory protein, ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) and the downstream protein, cyclin dependent kinase 6. Additionally, CF significantly enhanced p21 levels, reduced cyclin D1 protein levels and triggered cancer cell death. CF leaf extracts induced cell death, stimulated apoptosis and inhibited migration in HepG2 cells. Thus, CF may be useful for developing an anticancer drug candidate for the treatment of liver cancer.
28413643	0	9	Cytotoxic	T038	UMLS:C0596402
28413643	14	35	antimigratory effects	T038	UMLS:C1524058
28413643	39	55	Cratoxy formosum	T204	UMLS:C1219382
28413643	56	63	extract	T103	UMLS:C0032081
28413643	72	77	HepG2	T017	UMLS:C2717940
28413643	78	96	liver cancer cells	T017	UMLS:C2717940
28413643	120	125	study	T062	UMLS:C2603343
28413643	149	169	molecular mechanisms	T038	UMLS:C1148560
28413643	181	200	Cratoxylum formosum	T204	UMLS:C1219382
28413643	202	204	CF	T204	UMLS:C1219382
28413643	219	225	cancer	T038	UMLS:C0006826
28413643	226	236	cell death	T038	UMLS:C0007587
28413643	241	262	antimigratory effects	T038	UMLS:C1524058
28413643	266	271	HepG2	T017	UMLS:C2717940
28413643	272	290	liver cancer cells	T017	UMLS:C2717940
28413643	296	305	cytotoxic	T038	UMLS:C0596402
28413643	307	324	antiproliferative	T038	UMLS:C1156236
28413643	329	350	antimigratory effects	T038	UMLS:C1524058
28413643	354	356	CF	T204	UMLS:C1219382
28413643	357	369	leaf extract	T103	UMLS:C0032081
28413643	373	378	human	T204	UMLS:C0086418
28413643	379	391	liver cancer	T038	UMLS:C0345904
28413643	392	408	HepG2 cell lines	T017	UMLS:C2717940
28413643	430	446	sulforhodamine B	T103	UMLS:C0065078
28413643	448	464	colony formation	T058	UMLS:C0009385
28413643	470	490	wound healing assays	T058	UMLS:C0005507
28413643	505	514	apoptosis	T038	UMLS:C0162638
28413643	515	535	induction mechanisms	T038	UMLS:C1148560
28413643	558	581	reactive oxygen species	T103	UMLS:C0162772
28413643	558	597	reactive oxygen species (ROS) formation	T038	UMLS:C1148560
28413643	583	586	ROS	T103	UMLS:C0162772
28413643	599	619	caspase 3 activities	T038	UMLS:C1150132
28413643	625	657	mitochondrial membrane potential	T038	UMLS:C1720920
28413643	659	662	ΔΨm	T038	UMLS:C1720920
28413643	676	691	Gene expression	T038	UMLS:C0017262
28413643	696	705	apoptosis	T038	UMLS:C0162638
28413643	696	725	apoptosis -associated protein	T103	UMLS:C0033684
28413643	750	810	reverse transcription-quantitative polymerase chain reaction	T062	UMLS:C0599161
28413643	815	831	western blotting	T058	UMLS:C0005863
28413643	833	835	CF	T204	UMLS:C1219382
28413643	844	849	HepG2	T017	UMLS:C2717940
28413643	850	860	cell death	T038	UMLS:C0007587
28413643	1015	1024	Treatment	T058	UMLS:C0087111
28413643	1030	1032	CF	T204	UMLS:C1219382
28413643	1112	1126	cell migration	T038	UMLS:C1622501
28413643	1153	1158	study	T062	UMLS:C2603343
28413643	1177	1179	CF	T204	UMLS:C1219382
28413643	1188	1191	ROS	T103	UMLS:C0162772
28413643	1188	1201	ROS formation	T038	UMLS:C1148560
28413643	1213	1233	caspase 3 activities	T038	UMLS:C1150132
28413643	1249	1252	ΔΨm	T038	UMLS:C1720920
28413643	1265	1270	HepG2	T017	UMLS:C2717940
28413643	1271	1280	apoptosis	T038	UMLS:C0162638
28413643	1282	1284	CF	T204	UMLS:C1219382
28413643	1334	1363	cell cycle regulatory protein	T103	UMLS:C0674679
28413643	1365	1407	ras-related C3 botulinum toxin substrate 1	T103	UMLS:C0139880
28413643	1421	1451	small GTP binding protein Rac1	T103	UMLS:C0139880
28413643	1461	1479	downstream protein	T103	UMLS:C0033684
28413643	1481	1506	cyclin dependent kinase 6	T103	UMLS:C0252132
28413643	1522	1524	CF	T204	UMLS:C1219382
28413643	1548	1551	p21	T103	UMLS:C0288472
28413643	1568	1585	cyclin D1 protein	T103	UMLS:C0033684
28413643	1607	1613	cancer	T038	UMLS:C0006826
28413643	1614	1624	cell death	T038	UMLS:C0007587
28413643	1626	1628	CF	T204	UMLS:C1219382
28413643	1629	1642	leaf extracts	T103	UMLS:C0032081
28413643	1651	1661	cell death	T038	UMLS:C0007587
28413643	1674	1683	apoptosis	T038	UMLS:C0162638
28413643	1698	1707	migration	T038	UMLS:C1622501
28413643	1711	1722	HepG2 cells	T017	UMLS:C2717940
28413643	1730	1732	CF	T204	UMLS:C1219382
28413643	1765	1790	anticancer drug candidate	T103	UMLS:C0003392
28413643	1799	1808	treatment	T058	UMLS:C0087111
28413643	1812	1824	liver cancer	T038	UMLS:C0345904